p53 antibodies for immunohistochemistry
| Antibody | Reference (I) or contact person and year of analysis (II) | Dilution | Cut-off to define positivity |
|---|---|---|---|
| (I) Published studies | |||
| AB-6 | Jankevicius et al (2002)45 | 1:100 | 20% |
| BP5312 | Hake et al (1993)30 | NR | 10% |
| CM1 | van Ahlen et al (1997)39 | NR | <20%, 30–80%, >80%* |
| DO-1 | Schmitz-Draeger et al (1997)38 | 1:100 | 5% |
| Wolf et al (2001)44 | 1:100 | 20% | |
| DO-7 | Rödel et al (2000)41 | 1:50 | 10% |
| Friedrich et al (1997)37 | 1:100 | 5% | |
| Leissner et al (2001)43 | 1:100 | 20% | |
| pAB1801 | Serth et al (1995)36 | 1:50 | 20% |
| Kuczyk et al (1995)34 | 1:50 | 40% | |
| Krüger et al (2005)47 | 1:50 | 7% (observed median) | |
| (II) Unpublished studies | |||
| DO-1 | US#1:Lehnert TG (1998) | 1:100 | <10%, 10–20%, >20% |
| DO-1 and pAB1801 | US#4:Adler J (1998) | NR | DO-1: 9%, pAB1801: 7.2% (observed medians) |
| US#5:Gerber M (2003) | NR | various cut-offs used; eg, 40% | |
| unknown | US#2:Perez R (2001) | NR | various cut-offs used; eg, 25% |
| US#3:Kunkel A (1996) | NR | <20%, 20–80%, >80% | |
*Presumably printing mistake in source publication.
NR: not reported.